Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5499 USD | -5.44% | +13.10% | +5.26% |
May. 10 | Earnings Flash (KPRX) KIORA PHARMACEUTICALS Posts Q1 Revenue $16M | MT |
Mar. 25 | Kiora Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.26% | 15.27M | |
+9.53% | 114B | |
+11.56% | 104B | |
-13.84% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-4.76% | 17.89B | |
+7.39% | 14.28B | |
+35.84% | 12.55B |
- Stock Market
- Equities
- KPRX Stock
- News Kiora Pharmaceuticals, Inc.
- HC Wainwright Adjusts Kiora Pharmaceuticals Price Target to $3 From $5, Maintains Buy Rating